Clinical Trials Logo

Common Warts clinical trials

View clinical trials related to Common Warts.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02640820 Active, not recruiting - Common Warts Clinical Trials

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Start date: December 2015
Phase: Phase 2
Study type: Interventional

Warts are benign epidermal tumors caused by human papillomaviruses (HPVs). The active pharmaceutical ingredient DPCP has been used for many years as a compounded formulation in acetone for the treatment of warts, alopecia areata and more recently, cutaneous metastatic melanoma lesions. An improved topical ointment formulation of DPCP called Samcyprone™ will be evaluated for the treatment of common warts.